Prosecution Insights
Last updated: April 19, 2026

Examiner: MEDWAY, SCOTT J

Tech Center 3700 • Art Units: 3763 3783

This examiner grants 67% of resolved cases

Performance Statistics

66.9%
Allow Rate
-3.1% vs TC avg
923
Total Applications
+23.4%
Interview Lift
1389
Avg Prosecution Days
Based on 871 resolved cases, 2023–2026

Rejection Statute Breakdown

0.6%
§101 Eligibility
25.9%
§102 Novelty
44.4%
§103 Obviousness
25.8%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18484584 SAFETY MECHANISM FOR AN AUTOINJECTOR Non-Final OA Ypsomed AG
19296339 Infusion Set and Inserter Assembly Systems and Methods Non-Final OA DEKA Products Limited Partnership
18449499 DEVICES FOR FORMING IN SITU MICRONEEDLES AND METHODS THEREOF Non-Final OA University of Connecticut
18336148 SYSTEMS AND METHODS FOR DRUG DELIVERY TO OCULAR TISSUE Non-Final OA Regeneron Pharmaceuticals, Inc.
18556314 TUBULAR BODY KIT AND GASKET Non-Final OA KYOCERA Corporation
18313767 INSTRUMENT FOR A MEDICAMENT DELIVERY DEVICE THAT ACTS AS NEEDLE AND CANNULA Non-Final OA Insulet Corporation
18463757 MEDICAL DEVICE Non-Final OA TERUMO KABUSHIKI KAISHA
16982445 DESIGNS FOR TYMPANOSTOMY CONDUITS OR SUBANNULAR VENTILATION CONDUITS AND OTHER MEDICAL AND FLUIDIC CONDUITS Final Rejection Massachusetts Eye and Ear Infirmary
17125853 PERCUTANEOUSLY ADMINISTERED THERAPEUTIC SUBSTANCE FOR TREATMENT OF TARGET TISSUE Final Rejection GYRUS ACMI, INC. D/B/A OLYMPUS SURGICAL TECHNOLOGIES AMERICA
18332658 DYNAMIC CURVE ACCESS TOOL FOR COMPLEX ARCH ANATOMIES AND RADIAL ACCESS Final Rejection STRYKER EUROPEAN OPERATIONS LIMITED
18255204 System to Provide Multiple Infusions to a Patient Non-Final OA FRESENIUS VIAL SAS
18758133 Medicament Delivery Device and Actuation Mechanism for a Drug Delivery Device Final Rejection Sanofi-Aventis Deutschland GMBH
18757830 Medicament Delivery Device and Actuation Mechanism for a Drug Delivery Device Final Rejection Sanofi-Aventis Deutschland GMBH
18757999 Medicament Delivery Device and Actuation Mechanism for a Drug Delivery Device Non-Final OA Sanofi-Aventis Deutschland GMBH
18612838 METHOD FOR OPERATING AN OPHTHALMIC SURGICAL SYSTEM, AND OPHTHALMIC SURGICAL SYSTEM Non-Final OA Carl Zeiss Meditec AG
17637145 MEDICAL MICRODEVICE ANCHORING APPARATUS, INSTALLATION AND RETRIEVAL TOOLS, AND METHODS OF USING SAME Non-Final OA THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
18215492 DEVICE AND METHOD FOR SETTING THERAPEUTIC PARAMETERS FOR AN INFUSION DEVICE Non-Final OA Tandem Diabetes Care, Inc.
18106608 PHACOEMULSIFICATION SYSTEM WITH AUTOMATIC DETECTION OF EXTENSION TUBING Final Rejection JOHNSON & JOHNSON SURGICAL VISION, INC.
17124454 CASSETTE DESIGN AND SYSTEMS AND METHODS THEREOF Final Rejection Johnson & Johnson Surgical Vision, Inc.
17124431 ROTARY VALVE CONFIGURATION FOR A SURGICAL CASSETTE Final Rejection Johnson & Johnson Surgical Vision, Inc.
17124441 IRRIGATION/ASPIRATION PUMP HEAD AND BLADDER DESIGN AND METHODS Final Rejection Johnson & Johnson Surgical Vision, Inc.
18025718 INFUSION SITE RETAINER FOR MAINTAINING INFUSION TUBING Non-Final OA MedicaMetrix, Inc.
18497964 Valve for Regulating the Flow of A Liquid Non-Final OA BioFlo, LLC
18381563 ADAPTOR FOR INFUSION LINE IDENTIFICATION SYSTEM Non-Final OA ORION INNOVATIONS INC.
17236446 Atraumatic Occlusive System with Compartment for Measurement of Vascular Pressure Change Non-Final OA TriSalus Life Sciences, Inc.
18265115 OVER-THE-NEEDLE INTRAVENOUS INTRODUCER ASSEMBLY Non-Final OA TUCANN MEDICAL PTY LTD
18134382 FLUID SOURCE MANAGEMENT SYSTEM Final Rejection Kyra Medical, Inc.
18026941 FLUIDICS CONTROL FOR MICROSURGICAL DEVICES Non-Final OA MICROSURGICAL TECHNOLOGY, INC.
18111652 HYDRAULIC PUMPING SYSTEM FOR EXPRESSION OF BREAST MILK Non-Final OA Willow Innovations, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month